Durect Corporation

BioCryst Pharmaceuticals is a global biotech company with over three decades of experience in drug discovery, development, and commercialization. They are dedicated to developing novel medicines for complement-mediated and other rare diseases, aiming to restore a sense of freedom for patients. With a transparent and supportive culture, BioCryst empowers its employees to go beyond what they think is possible, transforming challenges into resilience. Driven by their commitment to improving the lives of patients, BioCryst listens to their needs, collaborates with advocacy organizations, and ensures that the right treatments reach those who need them most. Using a blend of pioneering technology and science, they deliver first-in-class or best-in-class oral small-molecule and protein therapeutics for complement-mediated and other rare diseases, breaking new ground in the field. Founded in 1986, BioCryst continues to expand its global presence, making extraordinary a reality for as many people as possible.Generated from the website

Southern Research: Solving the world's hardest problems

Take the elevator to the seventh floor, where people come here to address community issues, build on opportunities and achieve results. We welcome input and gifts from all who want to join with us to improve the life of the Birmingham region.